DUBLIN, Nov. 20, 2014 /PRNewswire/ --Research and Markets has announced the addition of the "Global Cushing's Syndrome Therapeutics Market 2015-2019" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
One major trend upcoming in this market is the increase in public awareness of Cushing's syndrome. This is expected to lead to an increase in the number of treatment-seeking patients, thereby giving rise to the consumption of medications.
According to the report, the major driving factor of the market is the presence of a huge unmet need in this rare disease area. Few FDA-approved drugs are available, and the use of off-label drugs can cause several adverse effects. Thus, drug makers have the opportunity to produce therapies which can give them an edge over others and seize a major portion of the total market.
Further, the report states that the adverse effects of the drugs used to treat Cushing's syndrome are a major challenge to the growth of the market. Patient incompatibility leads to an increase in the churn-out rate of the patients from the treatment. This results in restraining the market growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Disease Overview
08. Market Landscape
09. Market Segmentation by Class of Drugs
10. Market Segmentation by Route of Administration
11. Market Segmentation by Dosage Form
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
21. Pipeline Portfolio
22. Key Vendor Analysis
23. Other Reports in this Series
Companies Mentioned:
- Corcept Therapeutics
- HRA Pharma
- Novartis
- Aspireo Pharmaceuticals
- Cortendo
- ElexoPharm
- Ipsen
- Isis Pharmaceuticals
- Orphagen Pharmaceuticals
- Samaritan Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/xn5gzj/global_cushings
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
